In the context of SARS-CoV-2, IgA, IgM, and IgG antibody, ELISA assays using plasma or serum are employed to identify individuals with an adaptive immune response to SARS-CoV-2, indicating recent or past infection. This evidence concerns the gene CD40LG and infection.